Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 120
| शीर्षक | मुख्य जाँचकर्ता | शुरुवाती साल | निधीयन एजेंसी | ध्यानाकर्षण क्षेत्र |
|---|---|---|---|---|
| Development of some mammalian cell based models to screen potent leads that might inhibit viral infection | Prof Partha Roy, Indian Institute of Technology (IIT) Roorkee | 2020 | Drug repurposing for COVID-19 | |
| Preclinical Efficacy Validation In Non-Human Primate Stroke Model Of Anti-Thrombin-Clot Specific Streptokinase (ACSSK), With Dual Properties Of Fibrin Specific Clot Dissolution And Prevention Of Arterial Re-Occlusion, For The Treatment Of Acute Myocardial Infarction And Ischemic Stroke | Dr Yogendra Padwad, Scientist, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Pre-clinical validation on non-human primates for heart diseases |
| Designing virus-like particles as vaccine candidates against nCoV-19 Proposed express M (Membrane), N (Nucleocapsid), E (Envelope) and S (Spike) proteins of nCoV-19 simultaneously in HEK293 cells for generating virus-like particle | Prof Manidipa Banerjee, Indian Institute of Technology (IIT) Delhi | 2020 | Vaccine development for COVID-19 | |
| Identifying Possible Potent Inhibitors against COVID-19 via Computational Drug Repurposing Study | Dr Parimal Kar, Assistant Professor, Indian Institute of Technology (IIT) Indore | 2020 | Drug repurposing for COVID-19 | |
| Design of novel bactericidal molecules targeting a conserved bacterial transcription regulator | Dr Ranjan Sen, Scientist, Centre for DNA Fingerprinting and Diagnostics (CDFD), Telangana | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Drug design |
| Target identification and hit-to-lead optimization of SRI-12742 targeting MDR A baumannii | Dr Sidharth Chopra, Scientist, Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Drug discovery |
| Determination of biofilm pharmacodynamics of newly formulated, nano-conjugated antibiotics to optimize treatment and dosing of chronic, antibiotic-resistant biofilm infections | Dr Gopal Chandra Kundu, Scientist & Director, National Centre for Cell Science (NCCS), Maharashtra | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Pharmacodynamics |
| Development of Monitoring and Evaluation protocol for accelerated MDA (Mass Drug Administration) with IDA (Ivermectin, Diethylcarbamazine and Albendazole) for lymphatic filariasis elimination programme | Dr Jambulingam P, Director, Vector Control Research Centre (ICMR-VCRC), Puducherry | 2019 | Bill & Melinda Gates Foundation (BMGF), USA | Filariasis; Biostatistics |
| Centre of Excellence for Epilepsy - Phase - II | Dr. Manjari Tripathi, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi, Dr. Tapan Kumar Gandhi, Associate Professor, Indian Institute of Technology (IIT), Delhi, Dr. Pravat Mandal, Professor, National Brain Research Centre (NBRC), Gurugram | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |
| Development of PD-1/PDL-1 check point inhibitor(s) for adjuvant therapy | Dr. C Gopi Mohan, Associate Professor, Amrita Vishwa Vidyapeetham Amritapuri Campus (AVVAC), Kollam | 2018 | Department of Biotechnology (DBT), Government of India, New Delhi | Adjuvant therapy |